Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

510(k) Premarket Notification
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back To Search Results
Device Classification Name Next Generation Sequencing Based Tumor Profiling Test
510(k) Number K202304
Device Name NYU Langone Genome PACT (Genome Profiling of Actionable Cancer Targets)
Applicant
Nyu Langone Medical Center
240 E 38th St.
New York,  NY  10016
Applicant Contact Matija Snuderl
Correspondent
New York State Department of Health
Wadsworth Center, Empire State Plz.
P.O. Box 509
Albany,  NY  12237
Correspondent Contact Derek Symula
Regulation Number866.6080
Classification Product Code
PZM  
Date Received08/14/2020
Decision Date 07/14/2021
Decision Substantially Equivalent (SESE)
Regulation Medical Specialty Pathology
510k Review Panel Pathology
Statement Statement
FDA Review Decision Summary
Type Traditional
Reviewed by Third Party Yes
Combination Product No
Predetermined Change
Control Plan Authorized		 No
-
-